Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Matrix metalloproteinase inhibitors MMPIs

Hurwitz H, Humphrey J, Williams K, Ness E, Conway A, Bielefield M, et al. A phase I trial of BMS-275291 a novel, non-hydroxamate, sheddase-sparing matrix metalloproteinase inhibitor (MMPI) with no dose-limiting arthritis. Proc Anna Meet Am Soc Clin Oncol 2001 (abstract) submitted. [Pg.390]

Pavlaki, M., and Zucker, S., Matrix metalloproteinase inhibitors (MMPIs) The beginning of phase 1 or the termination of phase IB clinical trials. Cancer Metastasis Reviews 22, 177-203 (2003). [Pg.82]

Matrix metalloproteinase inhibitors (MMPIs) from marine natural products the current situation and future prospect. Zhang, G., Kim, S.-K. (2009) Mar. Drugs, 7, 71-84. [Pg.69]

See other pages where Matrix metalloproteinase inhibitors MMPIs is mentioned: [Pg.379]    [Pg.327]    [Pg.379]    [Pg.327]    [Pg.228]    [Pg.381]    [Pg.92]    [Pg.130]   
See also in sourсe #XX -- [ Pg.379 , Pg.380 , Pg.381 , Pg.382 ]



SEARCH



MMPIs

MMPIs inhibitors

Matrix inhibitor

Matrix metalloproteinase

Matrix metalloproteinase inhibitor

Matrix metalloproteinases

Matrix metalloproteinases inhibitors

Metalloproteinase

Metalloproteinase inhibitors

Metalloproteinases

© 2024 chempedia.info